Introduction: The pre-exposure prophylaxis (PrEP) is a globally recognized pharmacological approach, consisting of a daily dose of antiretroviral drugs used to reduce the contamination rate by the human immunodeficiency virus (HIV). This combined prevention program was first offered by the Brazilian public health system in 2017 and was provided by Testing and Counseling Centers. Objective: To analyze the profile of pre-exposure prophylaxis users seen at Testing and Counseling Centers in Curitiba (state of Paraná, Brazil) and the presence of HIV and other sexually transmitted infections, such as syphilis, hepatitis B and C, in these users. Methods: This is an analytical, cross-sectional study, using database provided by the information system of the Testing and Counseling Center. Results: Users of HIV pre-exposure prophylaxis are mostly young, white, single men, and who are part of the group of men who have sex with other men. It was verified that, even though the HIV pre-exposure prophylaxis plays a major role in HIV prevention, it is paramount to encourage combined prevention, considering there is a significant relationship between the lack of barrier methods and positive results for syphilis. Conclusion: No connection between the use of HIV pre-exposure prophylaxis and increased incidence of sexually transmitted infections was established in the present study. Keywords: Sexually transmitted infections. Pre-exposure prophylaxis. HIV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.